Platform Thesis Development & Execution
We partner with sponsors to pressure test, refine and execute a focused thesis utilizing a high-touch approach and our experience as the most active M&A firm in the health sciences.
The Crosstree Advantage
How can the Crosstree Advantage help you?
Platform Assessment
Using an industry-focused lens, we validate a potential investment's growth opportunity and evaluate execution feasibility to enhance buyer confidence.
Add-on Strategy Development & Execution
Our deep domain expertise and relationships within industry allow us to further develop value-enhancing growth strategies and execute with precision.
2.0 Growth Story
We maximize potential partner conviction by developing the blueprints for our client's next stage of growth that can be executed by investors or buyers post-transaction.
Latest Strategic Advisory and Origination Services Deals
Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering
Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities
Grant Avenue Capital Recapitalizes CREO
SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU
Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings
Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering
ClinChoice Acquires CROMSOURCE to Expand CRO Capabilities Globally
Clairvest Acquires Boca Biolistics to Accelerate Growth of Infectious Disease and Oncological Biobanking Capabilities
LongueVue Capital Partners Acquires Majority Stake in Summit Clinical Research to Accelerate SMO/IRO Growth
H.I.G. Capital Acquires Majority Stake in Navitas Life Sciences to Accelerate CRO Growth
Flourish Research Acquires Excel Medical Clinical Trials to Expand Site Network and Therapeutic Expertise
Pyxant Labs Receives Majority Investment from ArchiMed
dMed Merged with Clinipace
.png)